ConductScience.org, home

Paper15747762

Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial.

Good WV and 1 other. Trans Am Ophthalmol Soc, 2004. Cited by 531 papers, by iCite.

Cite this record

ConductScience Library. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Papers, record 15747762. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15747762

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial.
PubMed
Journal
Trans Am Ophthalmol Soc
PubMed
Year
2004
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
531
iCite
Relative citation ratio, by iCite
16.5
iCite
Revised in PubMed
2022-04-08
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Good WVWilliam V
2Early Treatment for Retinopathy of Prematurity Cooperative GroupGroup

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CryosurgeryMajor topic
Laser TherapyMajor topic
RetinaMajor topic
Retinopathy of PrematurityMajor topic
Female
Follow-Up Studies
Humans
Infant
Infant, Newborn
Male
Risk Factors
Time Factors
Treatment Outcome
Visual Acuity

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U10 EY012471NEI NIH HHSUnited StatesU10EY012471PubMed and NIHNIH RePORTER
U10 EY012472NEI NIH HHSUnited StatesU10EY012472PubMed and NIHNIH RePORTER
5U10 EY12471NEI NIH HHSUnited StatesU10EY012471PubMed and NIHNIH RePORTER
5U10 EY12472NEI NIH HHSUnited StatesU10EY012472PubMed and NIHNIH RePORTER

Download CSV of grants

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111061766Severity of neonatal retinopathy of prematurity is predictive of neurodevelopmental functional outcome at age 5.5 years. Behalf of the Cryotherapy for Retinopathy of Prematurity Cooperative Group.Pediatrics2000https://conductscience.org/library/papers/11061766PubMed
211382621The multicenter study of Early Treatment for Retinopathy of Prematurity (ETROP).Ophthalmology2001https://conductscience.org/library/papers/11382621PubMed
311483076Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years.Arch Ophthalmol2001https://conductscience.org/library/papers/11483076PubMed
412908531Laser treatment of zone I prethreshold and stage 3 threshold retinopathy of prematurity.J Pediatr Ophthalmol Strabismus2003https://conductscience.org/library/papers/12908531PubMed
514662586Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.Arch Ophthalmol2003https://conductscience.org/library/papers/14662586PubMed
614662587Risk analysis of prethreshold retinopathy of prematurity.Arch Ophthalmol2003https://conductscience.org/library/papers/14662587PubMed
715157731Multicenter trial of early treatment for retinopathy of prematurity: study design.Control Clin Trials2004https://conductscience.org/library/papers/15157731PubMed
86029467The Denver developmental screening test.J Pediatr1967https://conductscience.org/library/papers/6029467PubMed
97091289New visual acuity charts for clinical research.Am J Ophthalmol1982https://conductscience.org/library/papers/7091289PubMed
106547831An international classification of retinopathy of prematurity. The Committee for the Classification of Retinopathy of Prematurity.Arch Ophthalmol1984https://conductscience.org/library/papers/6547831PubMed
114019107The acuity card procedure: a rapid test of infant acuity.Invest Ophthalmol Vis Sci1985https://conductscience.org/library/papers/4019107PubMed
123817317Assessment of visual acuity in infants and children: the acuity card procedure.Dev Med Child Neurol1986https://conductscience.org/library/papers/3817317PubMed
132895630Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group.Arch Ophthalmol1988https://conductscience.org/library/papers/2895630PubMed
142211019Acuity card assessment of visual function in the cryotherapy for retinopathy of prematurity trial.Invest Ophthalmol Vis Sci1990https://conductscience.org/library/papers/2211019PubMed
152222274Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome--structure and function. Cryotherapy for Retinopathy of Prematurity Cooperative Group.Arch Ophthalmol1990https://conductscience.org/library/papers/2222274PubMed
161800923Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.Ophthalmology1991https://conductscience.org/library/papers/1800923PubMed
178031269The natural ocular outcome of premature birth and retinopathy. Status at 1 year. Cryotherapy for Retinopathy of Prematurity Cooperative Group.Arch Ophthalmol1994https://conductscience.org/library/papers/8031269PubMed
187890496Large sample population age norms for visual acuities obtained with Vistech-Teller Acuity Cards.Invest Ophthalmol Vis Sci1995https://conductscience.org/library/papers/7890496PubMed
197890497Monocular acuity norms for the Teller Acuity Cards between ages one month and four years.Invest Ophthalmol Vis Sci1995https://conductscience.org/library/papers/7890497PubMed
208602778Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1/2 years after randomization.Arch Ophthalmol1996https://conductscience.org/library/papers/8602778PubMed

See all 23 referencesDownload CSV of references

Cited by313

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 531 citations.

PMIDTitleJournalYearIn PapersSource
42926771Preliminary efficacy of intravitreal faricimab for type 1 retinopathy of prematurity: A pilot case series.Adv Ophthalmol Pract Res2026https://conductscience.org/library/papers/42926771PubMed
42861005Cost-Effectiveness of Telemedicine-Based Screening Programs for Retinopathy of Prematurity in Low- and Middle-Income Countries.Ophthalmol Sci2026https://conductscience.org/library/papers/42861005PubMed
42778673The predictive role of early and late-stage inflammatory markers in the development of retinopathy of prematurity in discordant twins.Eye (Lond)2026https://conductscience.org/library/papers/42778673PubMed
42610595Optimizing Field-of-View for Type-1 Retinopathy of Prematurity via Multiple Instance Learning.Transl Vis Sci Technol2026https://conductscience.org/library/papers/42610595PubMed
42592060Infants with retinopathy of prematurity (ROP) in Germany and Türkiye-a comparison based on data from the EU-ROP registry.Front Med (Lausanne)2026https://conductscience.org/library/papers/42592060PubMed
42549187Automatic Diagnosis of Plus Disease in Retinopathy of Prematurity Using Deep Learning.Beyoglu Eye J2026https://conductscience.org/library/papers/42549187PubMed
42510081Incidence and Risk Factors for Persistent Avascular Retina in Patients with a History of Retinopathy of Prematurity in Mexico.Diagnostics (Basel)2026https://conductscience.org/library/papers/42510081PubMed
42416136
Comparison of Success Rates Between Laser Photocoagulation and Intravitreal Anti-Vascular Endothelial Growth Factor Injection for the Treatment of Retinopathy of Prematurity in a Tertiary Referral Center: An 11-Year Survey.
J Clin Pract Res2026https://conductscience.org/library/papers/42416136PubMed
42399397Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease.Eye (Lond)2026https://conductscience.org/library/papers/42399397PubMed
42348596Erythropoietin, transfusions, and outcomes of retinopathy of prematurity and brain injury in extremely preterm infants: A post hoc analysis of the Preterm Erythropoietin Neuroprotection Trial (PENUT).PLoS One2026https://conductscience.org/library/papers/42348596PubMed
42211224Impact of different treatment approaches on long-term refractive and visual outcomes in retinopathy of prematurity.Int J Ophthalmol2026https://conductscience.org/library/papers/42211224PubMed
42145364Retinopathy of prematurity: Clinical profiles and risk factors.Bioinformation2026https://conductscience.org/library/papers/42145364PubMed
42094942Exposure to Type 1 and Type 2 Maternal Diabetes is Associated with Stage 3-5 Retinopathy of Prematurity.Ophthalmol Sci2026https://conductscience.org/library/papers/42094942PubMed
42073061Long-Term Sequelae of Retinopathy of Prematurity-A Scoping Review.Children (Basel)2026https://conductscience.org/library/papers/42073061PubMed
42043511Validation of the FIRST-ROP algorithm in a tertiary care center in Greece.Graefes Arch Clin Exp Ophthalmol2026https://conductscience.org/library/papers/42043511PubMed
41847074Quantitative Assessment of the Extent of Retinal Vascularization in Retinopathy of Prematurity.Ophthalmol Sci2026https://conductscience.org/library/papers/41847074PubMed
41838271From Science and Technology to Eye-Health Policy: A Review on Global and Asia-Pacific Strategies on the Prevention of Blindness from Retinal Diseases.Ophthalmol Ther2026https://conductscience.org/library/papers/41838271PubMed
41767769Adherence to Pediatric Ophthalmology Follow-Up After Completion of Retinopathy of Prematurity: A Retrospective Review.Patient Prefer Adherence2026https://conductscience.org/library/papers/41767769PubMed
41703253Variations in prevalence of retinopathy of prematurity (ROP) and completeness of screening in five units within a South African region: a register-based study.Eye (Lond)2026https://conductscience.org/library/papers/41703253PubMed
41498321Retinopathy of prematurity screening program for government neonatal intensive care units by a non-profit tertiary eye care center in India: A collaborative public health initiative.Indian J Ophthalmol2026https://conductscience.org/library/papers/41498321PubMed

See all 313 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15747762

GET https://conductscience.org/api/papers/v1/15747762/references?page=2